onset of tirzepatide equally effective for early-onset or later-onset type 2 diabetes Tirzepatide Side Effects: Timeline, Symptoms,

The GLP-1 component largely counteracts this by driving insulin secretion, but the net effect may require monitoring in people with diabetes or prediabetes

Because in our region, the challenge is not only innovation

doi: 10.3389/fnins.2013.00051

Patients should never initiate this combination without explicit physician guidance, as both medications require prescription authorization and medical supervision

Abstract 133: correlation of inflammatory markers with metabolic and hormonal parameters in first degree relatives of PCOS patients

Supplemental Material Supplemental material, sj-docx-1-eso-10.1177_23969873241234238 for Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis by Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra, Diana Aguiar de Sousa, Mira Katan, Lina Palaiodimou, Aristeidis H Katsanos, Ioanna Koutroulou, Vaia Lambadiari, Robin Lemmens, Sotirios Giannopoulos, Andrei V Alexandrov, Gerasimos Siasos and Georgios Tsivgoulis in European Stroke Journal Acknowledgments None Footnotes The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article